Brief: BLS Pharmaceuticals Reports Record Q1 FY27 Revenue Of A$26.7 Million
15/10/2026 01:51
BRIEF-BLS Pharmaceuticals Reports Record Q1 FY27 Revenue Of A$26.7 Million Oct 15 (Reuters) - BLS Pharmaceuticals Limited BLS.AX:
REPORTS RECORD Q1 FY27 REVENUE OF A$26.7 MILLION, UP 123% ANNUALISED
REAFFIRMS FY27 REVENUE GUIDANCE A$105 MILLION-A$115 MILLION, ADJUSTED EBITDA MARGIN 23%-26%
Further company coverage: BLS.AX
((Reuters.briefs@thomsonreuters.com;))
Recent news on BLS Pharmaceuticals
See all newsBrief: BLS Pharmaceuticals Posts Q1 FY27 Revenue A$26.7M
Brief: BLS Pharmaceuticals Reports Record Q1 FY27 Revenue Of A$26.7 Million
Australia's BLS Pharmaceuticals extends gains on upbeat outlook, strong results
Brief: BLS Pharmaceuticals Sees FY27 Adjusted. EBITDA Margin 23% - 26%
Brief: BLS Pharmaceuticals Posts FY Net Profit After Tax Of A$15.4 MLN